
Turning immune cells into cancer’s worst enemy: China’s CAR-T revolution
By Ji Juesu, People’s Daily In early March 2024, Mr. Zhou, a 63-year-old resident of Shanghai, returned to a hospital for what would become his third fight against diffuse large B-cell lymphoma. But this time, he was not relying on the chemotherapy and targeted therapy that had defined his previous treatments. Instead, he placed his…